Siegfried Kasper is an expert in Psychiatry at Essen University Hospital (Germany). As of October 2026, ScienceLeadR ranks Siegfried Kasper in the top 1% of experts worldwide for Seasonal Affective Disorder, Depressive Disorder and Mood Disorders. Siegfried Kasper has authored 1,174 publications, the most recent in 2026, and is an investigator in 17 clinical trials. SLR score: 3,535 (community average: 125). How the SLR is computed.

LeadR Profile

Siegfried Kasper Essen University Hospital Germany
3 535 ScienceLeadR Reputation 3535
Network Map

Psychiatry

Subspecialties: Pharmacy - Genetics - Neurology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Short Biography

Dr. Siegfried Kasper is Professor Emeritus of Psychiatry and former Chairman of the Department of Psychiatry and Psychotherapy at the Medical University of Vienna, Austria. Dr. Kasper published more than 800 in PubMed listed publications (Google: Citation Index: 73.791; Hirsch-Index: 134, i10-index: 831) and more than 250 books or book chapters, in various areas of psychiatry. Dr. Kasper serves/served on the executive committees and advisory boards of several national and international societies, such as the Austrian Association of Psychiatry, Psychotherapy and Psychosomatic (ÖGPP), the European College of Neuropsychopharmacology (ECNP) and the European Psychiatric Association (EPA). From 2005 to 2009 Dr. Kasper was President of the World Federation of Societies of Biological Psychiatry (WFSBP) and has been appointed as Honorary President of the WFSBP in 2013. He has been elected to the Executive Committee of the International College of Neuropsychopharmacology (CINP) for the period of 2012 to 2018 and is now President of this society. Moreover, Dr. Kasper is Chair of the World Psychiatric Association (WPA) Section of Pharmacopsychiatry. He is Founding President of the Austrian Society of Neuropsychopharmacology and Biological Psychiatry (ÖGPB) and of the Austrian Society of Drug Safety in Psychiatry (ÖAMSP). Furthermore, he is a Honorary Member of the Czech Society of Neuropsychopharmacology, the Romanian Society of Neuropsychopharmacology, the Hungarian Psychiatric Association and a Fellow of the Royal College of Psychiatrists, UK, as well as of the Scandinavian College of Neuro-Psychopharmacology (SCNP) and of the Ukrainian Association of Psychiatry. He is a member of the European Academy of Sciences and Arts (EASA). Furthermore, he has been appointed as Honorary/Visiting Professor at the following universities: University of Hong Kong, China, in 2004; Universidad Andrés Bello, Santiago de Chile, Chile, 2014; Aino University in Osaka, Japan, 2015; Kolkata Institute of Psychiatry, Department of Health & Family Welfare, India in 2016; University of Hiroshima, Japan, in 2017 and Belgrade University School of Medicine, Serbia, in 2017. Dr Kasper serves on editorial boards of numerous learned journals, including Journal of Affective Disorders, Pharmacopsychiatry, European Archives of Psychiatry and Neuroscience. He was Chief-Editor of the International Journal of Psychiatry in Clinical Practice and the World Journal of Biological Psychiatry. He was Field Editor of the International Journal of Neuropsychopharmacology as well as Section Editor of the Annals of General Psychiatry.

As a result of his research expertise he is the recipient of numerous national and international scientific and public awards and prizes and has been acknowledged with the Grand Decoration of Honor in Silver for Services to the Republic of Austria, the Austrian Cross of Honor for Science and Art, First Class, the Gold Medal for Meritorious Service to the Province of Vienna and received in 2019 the City of Vienna Award for Medical Science. In 2024 he was honored with the lifetime Achievement Award of the World Federation of Societies of Biological Psychiatry (WFSBP) and in 2025 with the Pioneer Award of the International College of Neuropsychopharmacology (CINP).


Organizations

Career arc: 1978 - 2026

Source: PubMed

Medical University of Vienna

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The American Society of Clinical Psychopharmacology (ASCP) task force on the deprescribing of psychotropic medications for mood disorders: Delphi expert consensus.
PMID 41877318 — mania, antidepressive agents, bipolar disorder, mood disorders, psychopharmacology, antipsychotic agents, psychiatry
Br J Psychiatry20260
Real-world survival benefit of adding durvalumab to chemotherapy in cholangiocarcinoma: a retrospective cohort analysis from a German Comprehensive Cancer Centre.
PMID 42828095 — biliary tract neoplasms, neoplasms, drug therapy, immune checkpoint inhibitors, therapeutics, cholangiocarcinoma, chemotherapy
ESMO Real World Data Digit Oncol20260
In memoriam: Professor Shigeto Yamawaki (January 15, 1954-June 8, 2026)-a visionary leader connecting Japan, Asia, and the world.
PMID 42574257
Int J Neuropsychopharmacol20260
Emerging pharmacological and neuromodulation interventions for suicidal ideation and behaviour.
PMID 42468074 — depression, therapeutics, suicidal ideation, suicide
Eur Neuropsychopharmacol20260
Topological data analysis communities reveal gene-environment-brain subtypes of major depression in UK Biobank and multi-site cohorts.
PMID 42431439 — depression, genes, neuroimaging, stress, physiological, brain, multiple chronic conditions, therapeutics, environment, data analysis, psychiatry
Biol Psychiatry20260

Clinical Studies 17

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5

By phase:

Phase 4 7
Phase 3 5
N/A 4
Phase 2 1

By status:

Completed 11
Unknown 4
Terminated 2

By type:

Interventional 14
Observational 3

By Monocentric/Multicentric:

monocentric 8
multicentric2to4 2
multicentric5to9 0
multicentricup10 7

Main Topics

Cohort/Consortium Investigators 1

LeadR Networks

Main global connection map